Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 18;13(14):2401.
doi: 10.3390/diagnostics13142401.

Evaluation of Hepatic/Renal and Splenic/Renal Echointensity Ratio Using Ultrasonography in Diabetic Nephropathy

Melike Elif Kalfaoglu  1
Affiliations

Evaluation of Hepatic/Renal and Splenic/Renal Echointensity Ratio Using Ultrasonography in Diabetic Nephropathy

Melike Elif Kalfaoglu. Diagnostics (Basel). .

Abstract

The objective of this study is to assess the hepatic/renal and splenic/renal echointensity ratios in ultrasonography in patients with and without diabetic nephropathy. This retrospective study included patients with diabetes mellitus who underwent ultrasound examinations at our hospital between January 2023 and May 2023. Ultrasound examinations were conducted using renal cortical echogenicity and corticomedullary differentiation by using B-mode ultrasonography. The hepatic/renal and splenic/renal echo intensity ratios were compared among study groups (diabetic patients with diabetic nephropathy and without nephropathy). The diabetic nephropathy group exhibited significantly higher right renal echointensity and left renal echointensity compared to the non-nephropathic group. Additionally, the splenic/renal echointensity ratio and hepatic/renal echointensity ratio were significantly lower in the diabetic nephropathy group. Urinary microalbumin levels were significantly correlated with right renal echointensity (r = 0.65, p < 0.001) and left renal echointensity (r = 0.69, p < 0.001). There was also a significant inverse correlation between the urinary albumin and splenic/renal echointensity ratio (r = -0.58, p < 0.001). Ultrasonography, specifically the assessment of hepatic/renal and splenic/renal echointensity ratios, shows promise as a noninvasive and cost-effective method for evaluating morphological changes in the kidneys in patients with diabetic nephropathy. These findings suggest that ultrasonography can be a valuable tool for monitoring the progression of diabetic nephropathy and contributing to its early detection and management.

Keywords: diabetic nephropathy; echointensity; type 2 diabetes mellitus; ultrasonography.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Hepatic/renal (a), and splenic/renal (b) echointensity measurements. The white circles correspond to the regions of interest used in the ultrasound analyses.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37((Suppl. S1)):S81–S90. doi: 10.2337/dc14-S081. - DOI - PubMed
    1. Fan W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc. Endocrinol. 2017;6:8–16. doi: 10.1097/XCE.0000000000000116. - DOI - PMC - PubMed
    1. Safiri S., Kolahi A.A., Naghavi M. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease study 2019. BMJ Glob. Health. 2021;6:e004128. doi: 10.1136/bmjgh-2020-004128. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . National Diabetes Statistics Report, 2017-Estimates of Diabetes and Its Burden in the United States Background. Centers for Disease Control and Prevention (CDC); Atlanta, GA, USA: 2017.
    1. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemiö K., Hämäläinen H., Härkönen P., Keinänen-Kiukaanniemi S., Laakso M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679. doi: 10.1016/S0140-6736(06)69701-8. - DOI - PubMed

Grants and funding

This research received no external funding.

LinkOut - more resources